These success, together with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 help the strategy of focusing on ACKR3 as a novel method to modulate the opioid system, which could open new therapeutic avenues for opioid-related Diseases. Conolidine CONOCB2™ primarily functions by https://williamm935het1.wikicommunications.com/user